Table 1.
Characteristic | % (n), or Mean ± SD (n) | Median (Range) |
---|---|---|
Demographics | ||
Age | 70 ± 10 (1678) | 72 (45-91) |
Female | 56% (1678) | - |
African American | 14% (1678) | - |
Study origin: ARIC | 26% (1678) | - |
HS Graduate | 69% (1673) | - |
Current Smoking | 13% (1678) | - |
Current Alcohol | 47% (1669) | - |
Medical History | ||
CVD | 34% (1665) | - |
Diabetes | 15% (1678) | - |
Hypertension | 74% (1677) | - |
Medication Usage | ||
Antihypertensive | 62% (1042/1678) | - |
Antihyperglycemic | 11% (185/1678) | - |
Lipid-Lowering | 6% (100/1678) | - |
Exam Findings | ||
BMI (kg/m2) | 27 ± 5 (1675) | 27 (17-53) |
SBP (mm Hg) | 135 ± 24 (1675) | 132 (74-228) |
DBP (mm Hg) | 72 ± 12 (1674) | 72 (24-136) |
LVH | 6% (1616) | - |
Laboratory Results | ||
Total Cholesterol | 215 ± 44 (1675) | 212 (86-465) |
HDL Cholesterol | 51 ± 16 (1672) | 48 (15-132) |
LDL Cholesterol | 133 ± 40 (1635) | 130 (14-387) |
Triglycerides | 153 ± 88 (1675) | 130 (24-954) |
Hemoglobin | 13.8 ± 1.6 (1668) | 13.8 (7.0-25.4) |
Uric Acid | 6.8 ± 1.8 (1678) | 6.7 (1.7-15.9) |
Albumin | 4.0 ± 0.3 (1678) | 4.0 (2.0-5.2) |
Fibrinogen | 334 ± 72 (1672) | 328 (132-854) |
Creatinine | 1.3 ± 0.4 (1678) | 1.3 (1.0-4.8) |
eGFR | 51 ± 9 (1678) | 53 (16-60) |
HS, High school; CVD, cardiovascular disease; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; LVH, left ventricular hypertrophy by electrocardiogram criteria; eGFR, estimated glomerular filtration rate (mL/min/1.73m2); cholesterol values, uric acid, fibrinogen and serum creatinine are in mg/dL. Serum albumin and hemoglobin are in g/dL.
To convert cholesterol values in mg/dL to mmol/L, multiply by 0.02586; triglycerides in mg/dL to mmol/L, multiply by 0.01129; hemoglobin in g/dL to g/L, multiply by 10; uric acid in mg/dL to μmol/L, multiply by 59.48; albumin in g/dL to g/L, multiply by 10; fibrinogen in mg/dL to μmol/L, multiply by 0.0294; creatinine in mg/dL to mol/L, multiply by 88.4; and eGFR in mL/min to mL/s, multiply by 0.01667.